PT - JOURNAL ARTICLE AU - Kumar, Ashutosh AU - He, Siran AU - Pollack, Lisa M. AU - Lee, Jun Soo AU - Imoisili, Omoye AU - Wang, Yu AU - Kompaniyets, Lyudmyla AU - Luo, Feijun AU - Jackson, Sandra L. TI - Hypertension-associated Medical Expenditures Among Privately Insured US Individuals Aged 18 to 64 Years in 2021 AID - 10.1101/2024.05.22.24307767 DP - 2024 Jan 01 TA - medRxiv PG - 2024.05.22.24307767 4099 - http://medrxiv.org/content/early/2024/05/23/2024.05.22.24307767.short 4100 - http://medrxiv.org/content/early/2024/05/23/2024.05.22.24307767.full AB - Background There are no recent estimates for hypertension-associated medical expenditures. This study aims to estimate hypertension-associated incremental medical expenditures among privately insured US adults.Methods We conducted a retrospective cohort study using IQVIA’s Ambulatory Electronic Medical Records-US dataset linked with PharMetrics Plus claims data. Privately insured adults aged 18–64 years with ≥1 blood pressure measurement in 2020–2021 were included.Hypertension was identified as having ≥1 diagnosis code or ≥ 2 blood pressure measurements of ≥140/90 mmHg, or ≥1 antihypertensive medication in 2021. Annual total expenditures were estimated using a generalized linear model (GLM) with gamma distribution and log-link function. Out-of-pocket (OOP) expenditures were estimated using a two-part model that included logistic and GLM regression. Overlap propensity-score weights from logistic regression were used to obtain a balanced sample on hypertension status.Results Among the 393,018 adults, 156556 (40%) were identified with hypertension. Compared to individuals without hypertension, those with hypertension had $2,926 (95% CI, $2,681–$3,170) higher total expenditures, and $328 (95% CI, $300–$355) higher OOP expenditures. Adults with hypertension had higher total inpatient ($3,272; 95% CI, $1,458–$5,086) and outpatient ($2,189; 95% CI, $2,009–$2,369) expenditures, when compared with those without hypertension. Hypertension-associated incremental total expenditures were higher for women ($3,242; 95% CI, $2,915–$3,569) than for men ($2,521; 95% CI, $2,139–$2,904).Conclusions Among privately insured US adults, hypertension was associated with higher medical expenditures, including higher inpatient and OOP expenditures. These findings may help assess the economic value of interventions effective in preventing hypertension.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe authors received no financial support for the research, authorship, and/or publication of this article.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All data in this study were deidentified, so institutional review board approval was not required.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesWe used IQVIA's proprietary datasets to conduct this analysis. The data cannot be shared publicly.